Adenine nucleotide metabolism in human blood - Important roles for leukocytes and erythrocytes

Journal of Thrombosis and Haemostasis

Volumn 3, Issue 10, 2005, Pages 2331-2339

  Heptinstall, Stan ^a,b   Johnson, A ^a   Glenn, J R ^a   White, A E ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^b QUEEN S MEDICAL CENTRE   (United Kingdom)

Author keywords

Adenine nucleotide metabolism; Erythrocytes; HPLC; Leukocytes; Platelets

Indexed keywords

ADENINE NUCLEOTIDE; HYPOXANTHINE; INOSINE;

ARTICLE; BLOOD CELL; ENDOTHELIUM CELL; ERYTHROCYTE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN EXPERIMENT; LEUKOCYTE; METABOLISM; MONONUCLEAR CELL; NEUTROPHIL; NORMAL HUMAN; PLASMA; PRIORITY JOURNAL; THROMBOCYTE; THROMBOCYTE AGGREGATION;

ADENOSINE DIPHOSPHATE; BLOOD; BLOOD CELLS; ERYTHROCYTES; HUMANS; HYPOXANTHINE; INOSINE; LEUKOCYTES; METABOLISM; PLATELET AGGREGATION;

EID: 28444462118     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1111/j.1538-7836.2005.01489.x     Document Type: Article

References (29)

1. 1 receptor mediates ADP-induced intracellular calcium mobilization and shape change in platelets. J Biol Chem 1998; 273: 2030-34.
2. Kunapuli SP. Functional characterization of platelet ADP receptors. Platelets 1998; 9: 343-51.
3. Gachet C. ADP receptors of platelets and their inhibition. Thromb Haemost 2001; 86: 222-32.
4. Kunapuli SP, Dorsam RT, Kim S, Quinton TM. Platelet purinergic receptors. Curr Opin Pharmacol 2003; 3: 175-80.
5. 2T receptor in amplification of human platelet activation, aggregation, secretion and procoagulant activity. Br J Haematol 2000; 110: 925-34.
6. Cattaneo M, Gachet C. ADP receptors and clinical bleeding disorders. Arterioscler Thromb Vasc Biol 1999; 19: 2281-85.
7. Rao AK. Inherited defects in platelet signaling mechanisms. J Thromb Haemost 2003; 1: 671-81.
8. Chopra V, Marmur JD, Cavusoglu E. The role of clopidogrel in the management of patients with ischemie heart disease. Cardiovasc Drugs Ther 2003; 17: 467-77.
9. Holmsen H. Platelet metabolism and activation. Semin Hematol 1985; 22: 219-40.
10. Lazarowski ER, Boucher RC, Harden TK. Mechanisms of release of nucleotides and integration of their action as P2X- and P2Y-receptor activating molecules. Mol Pharmacol 2003; 64: 785-95.
11. Soslau G, Youngprapakorn D. A possible dual physiological role of extracellular ATP in the modulation of platelet aggregation. Biochim Biophys Acta 1997; 1355: 131-40.
12. 1 receptor: similarities to the platelet ADP receptor. Mol Pharmacol 1998; 53: 727-33.
13. Hourani SMO. Discovery and recognition of purine receptor subtypes on platelets. Drug Dev Res 2001; 52: 140-49.
14. 12 receptor: a novel member of the P2Y family of receptors activated by extracellular nucleotides. Mol Pharmacol 2001; 60: 416-20.
15. Stafford NP, Pink AE, White AE, Glenn JR, Heptinstall S. Mechanisms involved in adenosine triphosphate-induced platelet aggregation in whole blood. Arterioscler Thromb Vasc Biol 2003; 23: 1928-33.
16. Glenn JR, White AE, Johnson A, Fox SC, Behan MWH, Dolan G, Heptinstall S. Leukocyte count and leukocyte ecto-nucleotidase are major determinants of the effects of adenosine triphosphate and adenosine diphosphate on platelet aggregation in human blood. Platelets 2005; 16: 159-70.
17. Coade SB, Pearson JD. Metabolism of adenine nucleotides in human blood. Circ Res 1989; 65: 531-37.
18. Crack BE, Pollard CE, Beukers MW, Roberts SM, Hunt SF, Ingall AH, McKechnie KCW, Uzerman AP, Leff P. Pharmacological and biochemical analysis of FPL 67156, a novel, selective inhibitor of ecto-ATPase. Br J Pharmacol 1995; 114: 475-81.
19. Pilla A, Emanuelli T, Frassetto SS, Battastini AMO, Dias RD, Sarkis JJF. ATP diphosphohydolase activity (apyrase, EC 3.6.1.5) in human blood platelets. Platelets 1996; 7: 225-30.
20. Rossatto ER, da Silva LB, Pereira GS, Bonan CD, Battastini JP, Ribeiro JP, Sarkis JJF. ATP diphosphohydrolase in human platelets from patients with coronary arteries heart disease. Platelets 2003; 14: 47-52.
21. Mattig S, Knoefler R, Deussen A. Modulation of adenine nucleotide concentrations in human plasma by erythrocytes and endothelial cells. Thromb Res 2003; 110: 195-202.
22. Van Rompay AR, Johansson M, Karlsson A. Phosphorylation of nucleosides and nucleoside analogs by mammalian nucleoside mono-phosphate kinases. Pharmacol Ther 2000; 87: 189-98.
23. Zimmermann H. Extracellular metabolism of ATP and other nucleotides. Naunyn Schmiedeberg's Arch Pharmacol 2000; 362: 299-309.
24. Griffith DA, Jarvis SM. Nucleoside and nucleobase transport systems of mammalian cells. Biochim Biophys Acta 1996; 1286: 153-81.
25. Trams EG, Kaufmann H, Burnstock G. A proposal for the role of ecto-enzymes and adenylates in traumatic shock. J Theor Biol 1980; 87; 609-21.
26. Sprung R, Sprague R, Spence D. Determination of ADP release from erythrocytes using microbore tubing as a model of resistance vessels in vivo. Anal Chem 2002; 74: 2274-78.
27. Olearczyk JJ, Ellsworth ML, Stephenson AH, Lonigro AJ, Sprague RS. Nitric oxide inhibits ATP release from erythrocytes. J Pharmacol Exp Ther 2004; 309: 1079-84.
28. Marcus AJ, Broekman MJ, Drosophoulous JHF, Islam N, Pinsky DJ, Sesti C, Levi R. Metabolic control of excessive extracellular nucleotide accumulation by CD39/ecto-nucleotidase-l: Implications for ischemie vascular diseases. J Pharmacol Exp Ther 2003; 305: 9-16.
29. Beukers MW, Pirovano IM, van Weert A, Kerkhof CJM, Ijzerman AP, Soudijn W. Characterization of ecto-ATPase on human blood cells: a physiological role in platelet aggregation. Biochem Pharmacol 1993; 46: 1959-66.